shikonin

a naphthazarin; has antineoplastic and angiogenesis inhibiting activities

Also Known As:

(+)-shikonin; (+-)-shikonin; (R)-(+)-shikonin; 1,4-naphthalenedione, 5,8- dihydroxy- 2- ((1R)- 1- hydroxy- 4- methyl- 3- penten- 1- yl)- ; 1,4-naphthalenedione, 5,8- dihydroxy- 2- ((1r)- 1- hydroxy- 4- methyl- 3- pentenyl)- ; 1,4-naphthalenedione, 5,8- dihydroxy- 2- (1- hydroxy- 4- methyl- 3- pentenyl)- , (R)-; 1,4-naphthoquinone, 5,8- dihydroxy- 2- (1- hydroxy- 4- methyl- 3- pentenyl)- , (+)-; 2- ((1R)- 1- hydroxy- 4- methyl- 3- pentenyl)- 5,8- dihydroxy- 1,4- naphthoquinone; 5,8- dihydroxy- 2- ((1R)- 1- hydroxy- 4- methyl- 3- penten- 1- yl)- 1,4- naphthalenedione; 5,8- dihydroxy- 2- (1- hydroxy- 4- methyl- 3- pentenyl)- 1,4- naphthalenedione; isoarnebin 4; shikonin, (+)-isomer

Pharmalogical Action Categories:

D000894 - Anti-Inflammatory Agents, Non-Steroidal

Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Polycyclic Aromatic Hydrocarbons: 2081
        Naphthalenes: 18
        Naphthoquinones: 431
        shikonin: 577
- Quinones: 443
  - Naphthoquinones: 431
    - shikonin: 577
Polycyclic Compounds: 7
- Polycyclic Aromatic Hydrocarbons: 2081
  - Naphthalenes: 18
    - Naphthoquinones: 431
      - shikonin: 577

He-Wei Li Selected Research

He-Wei Li Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure